Outcomes in Patients With Postchemotherapy Residual Nonretroperitoneal Disease in Nonseminomatous Germ Cell Tumors

dc.contributor.authorKing, Jennifer
dc.contributor.authorAshkar, Ryan
dc.contributor.authorKesler, Kenneth
dc.contributor.authorAlthouse, Sandra K.
dc.contributor.authorHanna, Nasser H.
dc.contributor.authorEinhorn, Lawrence H.
dc.contributor.authorAdra, Nabil
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2024-12-09T09:15:21Z
dc.date.available2024-12-09T09:15:21Z
dc.date.issued2024
dc.description.abstractThis case-control study assesses the association between teratoma in the primary tumor or postchemotherapy resections and survival outcomes.
dc.identifier.citationKing J, Ashkar R, Kesler K, et al. Outcomes in Patients With Postchemotherapy Residual Nonretroperitoneal Disease in Nonseminomatous Germ Cell Tumors. JAMA Oncol. 2024;10(1):132-134. doi:10.1001/jamaoncol.2023.4949
dc.identifier.urihttps://hdl.handle.net/1805/44816
dc.language.isoen_US
dc.publisherAmerican Medical Association
dc.relation.isversionof10.1001/jamaoncol.2023.4949
dc.relation.journalJAMA Oncology
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectTesticular neoplasms
dc.subjectLymph node excision
dc.subjectResidual neoplasm
dc.titleOutcomes in Patients With Postchemotherapy Residual Nonretroperitoneal Disease in Nonseminomatous Germ Cell Tumors
dc.typeArticle
ul.alternative.fulltexthttps://pmc.ncbi.nlm.nih.gov/articles/PMC10636653/
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
King2023Outcomes-PP.pdf
Size:
509.58 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: